The molecular point of care testing (POCT) market is a rapidly evolving segment of the global diagnostics and healthcare technology industry. Molecular POCT refers to diagnostic testing performed at or near the site of patient care using nucleic acid amplification tests (NAAT) to detect genetic material from pathogens. These tests provide rapid, highly sensitive, and accurate results,... https://www.databridgemarketresearch.com/reports/global-molecular-point-of-care-testing-using-naat-market